<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The determinants of cerebral complications of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are unclear </plain></SENT>
<SENT sid="1" pm="."><plain>The present study aimed to identify metabolic and vascular factors that are associated with impaired cognitive performance and abnormalities on brain MRI in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The study included 122 patients and 56 controls </plain></SENT>
<SENT sid="3" pm="."><plain>Neuropsychological test scores were divided into five cognitive domains and expressed as standardised z values </plain></SENT>
<SENT sid="4" pm="."><plain>Brain MRI scans were rated for white matter lesions (WML), cortical and subcortical <z:mpath ids='MPATH_127'>atrophy</z:mpath>, and <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Data on <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, vascular risk factors and micro- and macrovascular disease were collected </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had more cortical (p &lt; 0.001) and subcortical (p &lt; 0.01) <z:mpath ids='MPATH_127'>atrophy</z:mpath> and deep WML (p = 0.02) than the control group and their cognitive performance was worse </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate regression analyses within the type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> group, <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p &lt; 0.05) and a history of vascular events (p &lt; 0.01) were associated with worse cognitive performance, while <z:chebi fb="0" ids="35664">statin</z:chebi> use was associated (p &lt; 0.05) with better performance </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000488'>Retinopathy</z:hpo> and brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> on MRI were associated with more severe <z:hpo ids='HP_0002120'>cortical atrophy</z:hpo> (both p &lt; 0.01) and <z:chebi fb="0" ids="35664">statin</z:chebi> use with less <z:mpath ids='MPATH_127'>atrophy</z:mpath> (p &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Insulin level and brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> were associated with more severe WML and <z:chebi fb="0" ids="35664">statin</z:chebi> use with less severe WML (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with modest impairments in cognition, as well as <z:mpath ids='MPATH_127'>atrophy</z:mpath> and vascular lesions on MRI </plain></SENT>
<SENT sid="11" pm="."><plain>This 'diabetic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo>' is a multifactorial condition, for which atherosclerotic (macroangiopathic) <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> is an important determinant </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> may play additional roles </plain></SENT>
</text></document>